Arnedos M, Bihan C, Delaloge S, Andre F (2012) Triple-negative breast cancer: are we making headway at least? Ther Adv Med Oncol 4(4):195–210. https://doi.org/10.1177/1758834012444711

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casara P, Davidson J, Claperon A et al (2018) S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth. Oncotarget 9:20075–20088

Article  PubMed  PubMed Central  Google Scholar 

Davis AP, Grondin CJ, Johnson RJ et al (2017) The comparative toxicogenomics database: update 2017. Nucleic Acids Res 45:D972–D978

Article  CAS  PubMed  Google Scholar 

Davis AP, Wiegers TC, Grondin CJ et al (2020) Leveraging the comparative toxicogenomics database to fill in knowledge gaps for environmental health: a test case for air pollution-induced cardiovascular disease[J]. Toxicol Sci 177(2):392–404

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gajiwala KS, Wu JC, Christensen J et al (2009) KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients. Proc Natl Acad Sci U S A 106(5):1542–1547

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao J, Li SJ (2018) Recent advances in network pharmacology applications in Chinese herbal medicine. Tradit Med Res 3(6):260–272

Article  Google Scholar 

Hao J, Jin Z, Zhu H et al (2018) Antiestrogenic activity of the Xi-Huang formula for breast cancer by targeting the estrogen receptor α. Cell Physiol Biochem 47(6):2199–2215. https://doi.org/10.1159/000491533

Article  CAS  PubMed  Google Scholar 

Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4(11):682–690. https://doi.org/10.1038/nchembio.118

Article  CAS  PubMed  Google Scholar 

Jinlong R, Peng L, Jinan W et al (2014) TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminformatics 6(1):13

Article  Google Scholar 

Kale J, Osterlund EJ, Andrews DW (2018) BCL-2 family proteins: changing partners in the dance towards death[J]. Cell Death Differ 25(1):65–80

Article  CAS  PubMed  Google Scholar 

Li Y, Jiang B, Wang R, Wang J, Li Y, Bao Y (2020) Synergistic effects of tanshinone IIA and andrographolide on the apoptosis of cancer cells via crosstalk between p53 and reactive oxygen species pathways. Pharmacol Rep 72(2):400–417. https://doi.org/10.1007/s43440-019-00006-z

Article  CAS  PubMed  Google Scholar 

Lin C, Wang L, Wang H, Yang L, Guo H, Wang X (2013) Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways. J Cell Biochem 114(9):2061–2070

Article  CAS  PubMed  Google Scholar 

Liu Z, Guo F, Wang Y et al (2016) BATMAN-TCM: a bioinformatics analysis tool for molecular mechanism of traditional Chinese medicine[J]. Sci Rep 6:21146

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Hao J, Niu Y, Wu X (2021) Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients. J Cancer Res Clin Oncol 147(7):2079–2092

Article  CAS  PubMed  Google Scholar 

Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) (2009) Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. J Computational Chemistry 16:2785–2791

Article  Google Scholar 

Planken S, Behenna DC, Nair SK et al (2017) Discovery of N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through structure-based drug design: a high affinity irreversible inhibitor targeting oncogenic EGFR mutants with selectivity over wild-type EGFR. J Med Chem 60(7):3002–3019

Article  CAS  PubMed  Google Scholar 

Powell E, Shao J, Yuan Y et al (2016) p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer[J]. Breast Cancer Res 18(1):13

Article  PubMed  PubMed Central  Google Scholar 

Qin J, Clore GM, Kennedy WM, Huth JR, Gronenborn AM (1995) Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B. Structure 3:289–297

Article  CAS  PubMed  Google Scholar 

Shah SP, Roth A, Goya R et al (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers[J]. Nature 486(7403):395–399

Article  CAS  PubMed  Google Scholar 

Su CC (2018) Tanshinone IIA can inhibit MiaPaCa-2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways. Oncol Rep 40(5):3102–3111. https://doi.org/10.3892/or.2018.6670

Article  CAS  PubMed  Google Scholar 

Suad O, Rozenberg H, Brosh R, Diskin-Posner Y, Kessler N, Shimon LJW, Frolow F, Liran A, Rotter V, Shakked Z (2009) Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations. J Mol Biol 385:249–265

Article  CAS  PubMed  Google Scholar 

Sui H, Zhao J, Zhou L et al (2017) Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer. Cancer Lett 403:86–97

Article  CAS  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Szklarczyk D, Franceschini A, Wyder S et al (2014) STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43:D447–D452

Article  PubMed  PubMed Central  Google Scholar 

Taira N, Nihira K, Yamaguchi T et al (2007) DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage[J]. Mol Cell 25(5):725–738

Article  CAS  PubMed  Google Scholar 

Trisciuoglio D, De Luca T, Desideri M et al (2013) Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth[J]. Neoplasia 15(3):315–327

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vickers CJ, González-Páez GE, Wolan DW (2013) Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids. ACS Chem Biol 8(7):1558–1566

Article  CAS  PubMed  Google Scholar 

Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321(3):288–300. https://doi.org/10.1001/jama.2018.19323

Article  CAS  PubMed  Google Scholar 

Wang R, Luo Z, Zhang H, Wang T (2019) Tanshinone IIA reverses gefitinib-resistance in human non-small-cell lung cancer via regulation of VEGFR/Akt pathway. Onco Targets Ther. 12:9355–9365. https://doi.org/10.2147/OTT.S221228

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Zhang S, Li F et al (2020) Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics[J]. Nucleic Acids Res 48(D1):D1031–D1041

CAS  PubMed  Google Scholar 

Wu Q, Zheng K, Huang X, Li L, Mei W (2018) Tanshinone-IIA-based analogues of imidazole alkaloid act as potent inhibitors to block breast cancer invasion and metastasis in vivo. J Med Chem 61(23):10488–10501. https://doi.org/10.1021/acs.jmedchem.8b01018

Article  CAS  PubMed  Google Scholar 

Xian MH, Zhan SK, Zheng KN et al (2021) Neuroprotective effect and mechanism of daidzein in oxygen-glucose deprivation/reperfusion injury based on experimental approaches and network pharmacology. Tradit Med Res 6(5):41

Article  CAS  Google Scholar 

Xu Z, Chen L, Xiao Z et al (2018) Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA. Phytomedicine 51:58–67. https://doi.org/10.1016/j.phymed.2018.05.012

Article  CAS  PubMed  Google Scholar 

Xue J, Jin X, Wan X et al (2019) Effects and mechanism of tanshinone II A in proliferation apoptosis and migration of human colon cancer cells. Med Sci Monit. 25:4793–4800. https://doi.org/10.12659/MSM.914446

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang J, Cron P, Good VM, Thompson V, Hemmings BA, Barford D (2002) Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat Struct Biol 9(12):940–944

Article  CAS  PubMed  Google Scholar 

Zhou H, Chen J, Meagher JL et al (2012) Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffold [published correction appears in. J Med Chem. 55(10):4664–4682

Article  CAS  PubMed  PubMed Central